| Limited environmental serine and glycine confer brain metastasis sensitivity to PHGDH inhibition B Ngo, E Kim, V Osorio-Vasquez, S Doll, S Bustraan, RJ Liang, A Luengo, ... Cancer discovery 10 (9), 1352-1373, 2020 | 168 | 2020 |
| Dietary fructose improves intestinal cell survival and nutrient absorption SR Taylor, S Ramsamooj, RJ Liang, A Katti, R Pozovskiy, N Vasan, ... Nature 597 (7875), 263-267, 2021 | 159 | 2021 |
| Comparative profiles of BRAF inhibitors: the paradox index as a predictor of clinical toxicity CH Adelmann, G Ching, L Du, RC Saporito, V Bansal, LJ Pence, R Liang, ... Oncotarget 7 (21), 30453, 2016 | 72 | 2016 |
| A Preexisting Rare PIK3CAE545K Subpopulation Confers Clinical Resistance to MEK plus CDK4/6 Inhibition in NRAS Melanoma and Is Dependent on S6K1 … G Romano, PL Chen, P Song, JL McQuade, RJ Liang, M Liu, W Roh, ... Cancer discovery 8 (5), 556-567, 2018 | 59 | 2018 |
| Blocking ActRIIB and restoring appetite reverses cachexia and improves survival in mice with lung cancer AL Queiroz, E Dantas, S Ramsamooj, A Murthy, M Ahmed, ERM Zunica, ... Nature Communications 13 (1), 4633, 2022 | 32 | 2022 |
| TNIK is a therapeutic target in lung squamous cell carcinoma and regulates FAK activation through Merlin P Torres-Ayuso, E An, KM Nyswaner, RC Bensen, DA Ritt, SI Specht, ... Cancer discovery 11 (6), 1411-1423, 2021 | 28 | 2021 |
| GLUT5 (SLC2A5) enables fructose-mediated proliferation independent of ketohexokinase RJ Liang, S Taylor, N Nahiyaan, J Song, CJ Murphy, E Dantas, S Cheng, ... Cancer & Metabolism 9, 1-13, 2021 | 19 | 2021 |
| MEK is a therapeutic and chemopreventative target in squamous cell carcinoma CH Adelmann, KA Truong, RJ Liang, V Bansal, L Gandee, R Saporito, ... The Journal of investigative dermatology 136 (9), 1920, 2016 | 17 | 2016 |
| Limited Environmental Serine and Glycine Confer Brain Metastasis Sensitivity to PHGDH Inhibition. Cancer Discov 10, 1352–1373, doi: 10.1158/2159-8290 B Ngo, E Kim, V Osorio-Vasquez, S Doll, S Bustraan, RJ Liang, A Luengo, ... CD-19-1228, 2020 | 10 | 2020 |
| Genetic and cellular contributions to liver regeneration R Liang, YH Lin, H Zhu Cold Spring Harbor Perspectives in Biology 14 (9), a040832, 2022 | 6 | 2022 |
| LKB1-dependent regulation of TPI1 creates a divergent metabolic liability between human and mouse lung adenocarcinoma BD Stein, JR Ferrarone, EE Gardner, JW Chang, D Wu, PE Hollstein, ... Cancer discovery 13 (4), 1002-1025, 2023 | 5 | 2023 |
| Systemic ketone replacement does not improve survival or Cancer Cachexia in mice with Lung Cancer HT Langer, S Ramsamooj, RJ Liang, R Grover, SK Hwang, ... Frontiers in Oncology 12, 903157, 2022 | 5 | 2022 |
| Microparticle-delivered Cxcl9 prolongs Braf inhibitor efficacy in melanoma G Romano, F Paradiso, P Li, P Shukla, LN Barger, O El Naggar, JP Miller, ... Cancer immunology research 11 (5), 558-569, 2023 | 2 | 2023 |
| Non-conserved metabolic regulation by LKB1 distinguishes human and mouse lung adenocarcinoma BD Stein, JR Ferrarone, EE Gardner, JW Chang, D Wu, Q Chen, ... bioRxiv, 2021.10. 01.462764, 2021 | 1 | 2021 |
| Nutrient scarcity confers breast cancer brain metastasis sensitivity to serine synthesis pathway inhibition B Ngo, E Kim, S Doll, S Bustraan, A Luengo, SM Davidson, A Ali, ... Cancer Research 80 (16_Supplement), 5712-5712, 2020 | 1 | 2020 |
| Restoring adiponectin via rosiglitazone ameliorates tissue wasting in mice with lung cancer HT Langer, S Ramsamooj, E Dantas, A Murthy, M Ahmed, SK Hwang, ... bioRxiv, 2023 | | 2023 |
| Blocking ActRIIB signaling and restoring appetite reverses cachexia and improves survival in mice with lung cancer AL Queiroz, S Ramsamooj, E Dantas, E Zunica, R Liang, A Murthy, ... | | 2021 |
| DDRE-22. TARGETING SERINE SYNTHESIS IN BRAIN METASTASIS B Ngo, E Kim, V Osorio-Vasquez, S Doll, S Bustraan, R Liang, A Luengo, ... Neuro-oncology Advances 3 (Suppl 1), i11, 2021 | | 2021 |
| BRAF inhibition and nanoparticle-delivered cytokine therapy for melanoma: A novel rational combined approach G Romano, R Liang, P Francesca, J Miller, F Taraballi, J Costello, ... Cancer Research 80 (16_Supplement), 908-908, 2020 | | 2020 |
| The protein kinase TNIK: a novel druggable target in Lung Squamous Cell Carcinoma with 3q amplification. PT Ayuso, E An, D Ritt, K Nyswaner, S Specht, R Liang, S Das, ... The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
